Due Diligence

qed biomedical can help investors identify the risks in early biotechnology innovations; providing optimal decision making.

Before investment are you sure?

• The preclinical evidence is reproducible?

• The models/tissue samples represent the disease?

• There is an in depth biological understanding of the target?

• You know the evidence gaps and evidence strengths?


We provide transparent summaries of novel technologies, indicating strengths and weaknesses in the evidence.

Importantly your decision will be evidence-based and unbiased.